Biosimilar Suits: Another Court To Rule On Declaratory Judgement Timing

Infringement suits have become routine, but Amgen’s, Celltrion’s and Teva’s suits against Genentech’s patents illustrate new trend by biosimilar sponsors to seek declaratory judgements of noninfringement.